Assistant Professor
Medical Director, Immunohistochemistry
Department of Pathology
The University of Chicago
5841 S. Maryland Ave.
MC 0008, Room TW-055B
Chicago, IL 60637
Office: (773) 702-5273
Fax: (773) 702-1200
girish.venkataraman@uchospitals.edu
Clinical Interests
Dr. Venkataraman oversees the immunohistochemistry lab located in the Clinical Hematology laboratory. He is part of the hematopathology team which handles the routine bone marrow biopsies/aspirates, lymph node biopsies, and other heme-related material, and on the Clinical Hematology Lab service dealing with body fluid/CSF analysis.
Research Interests
Dr. Venkataraman's main area of interest is in the identification of prognostic biomarkers in classical Hodgkin lymphoma (cHL). He recently demonstrated that aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with worse outcome. Another recent work demonstrating the expression of CD15- an antigen traditionally restricted to cHLs- in cases of Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) underscores the existence of grey zones between these two otherwise clinically and histologically distinct subtypes of Hodgkin lymphoma.
select Publications
- Nicolae A, Pittaluga S, Venkataraman G, and Jaffe ES et al. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol. 2013 Jun;37(6):816-26
- Venkataraman G, Song JY, Pittaluga S, and Jaffe ES et al. Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood. 2013 Mar 7;121(10):1795-804.
- Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma. Histopathology. 2011 Apr;58(5):803-5.
- Dojcinov SD, Venkataraman G, Pittaluga S, Wlodarska I, Schrager JA, Raffeld M,Hills RK, Jaffe ES. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011 May 5;117(18):4726-35.
